PRA Health Sciences Profit Margin

PRA Health Sciences (PRAH) currently reports a profit margin of 6.4% as of March 2021. That compares with 7.66% in the prior-year period — down 16.5% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore PRA Health Sciences's profit margin history and peer comparisons.

PRA Health Sciences's profit margin decreased from 7.66% to 6.4% — a 16.5% year-over-year decrease (period ending March 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PRA Health Sciences's profit margin of 6.4% is lower than the Healthcare sector average of 13.89%. That is roughly 53.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but PRA Health Sciences's current 6.4% should be judged against Healthcare norms (sector average: 13.89%) and against PRAH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 6.4%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for PRA Health Sciences, and consider following PRAH for alerts when major investors trade the stock.